Telix Pharmaceuticals Logo
Telix Pharmaceuticals Logo
  • Our Company
    • Our Company
    • Purpose, Mission & Values
    • Board & Management
    • Our Technology
    • Sustainability
  • Our Portfolio
    • Our Portfolio
    • Disease Areas
      • Prostate Cancer
      • Kidney Cancer
      • Brain Cancer
      • Musculo-skeletal cancers
    • Clinical Trials
    • Illuccix® & Gozellix®
    • Pipeline
    • Research & Innovation
  • Investor Centre
  • News & Views
  • Careers
    • Careers
    • Find a job
Header Image Frame Header Image Frame

Home News Page 41

News & Views

Latest News

Category: News

See all

Business Update : COVID-19

News,

Telix provides an update on the Company’s risk management assessment of the novel coronavirus (COVID-19)...

Read more

Leader in Prostate Cancer Imaging Prof. Frederik L. Giesel Joins Scientific Advisory Board

News,

Telix Pharmaceuticals Limited is pleased to announce that Professor Dr. Frederik L. Giesel, MD, MBA has joined Telix’s Scientific Advisory Board...

Read more

Positive FDA Feedback on NDA Submission Process for TLX591-CDx (kit for the preparation of 68Ga-PSMA-11)

ASX, News,

Telix Pharmaceuticals announces that it has received positive feedback from the FDA regarding its submission of an NDA for...

Read more

Telix Pharmaceuticals Releases Annual Report Year Ending 2019

ASX, News,

Telix Pharmaceuticals Limited Releases Annual Report Year Ending...

Read more

European Leadership Changes and Appointment of VP Sales and Marketing, EMEA

News,

Telix Pharmaceuticals Limited announces that Ms Odile Jaume will be stepping down from her position of Telix EU...

Read more

Telix Supports Molecular Imaging Summer Program at MSKCC

Events, News,

Telix Pharmaceuticals Ltd is pleased to announce our support of the Molecular Imaging Summer Program at...

Read more

Telix Granted FDA Approval for ZIRCON Renal Cancer Imaging

Clinical, News,

Telix Pharmaceuticals Limited is pleased to announce that the FDA has approved the ZIRCON study for American...

Read more

Robyn Jackson, MBA, CNMT Joins Telix Pharmaceuticals US

News,

With over 15 years of hands-on experience in Diagnostic Imaging and Sales, Robyn will be solidifying our presence in the Western US. Robyn has an extensive background in Diagnostic Imaging...

Read more

Anthony Zinno, MBA Joins Telix Pharmaceuticals US

News,

With more than 26 years of operations experience in the healthcare and life sciences field, Tony will be leading the sales organization as Vice President of Commercial Operations. Tony’s success...

Read more

NDA Clinical Briefing Package Submitted to the US FDA

Clinical, News,

Telix Pharmaceuticals announces that it has submitted a complete clinical briefing package to the US FDA for its first product...

Read more

Posts pagination

1 … 40 41 42 … 45

Subscribe

* indicates required

By subscribing, you are agreeing to the terms of our Global Privacy Policy and provide consent to receive updates from Telix”

Telix Pharmaceuticals Logo
  • Our Company
  • Contact
  • Our Portfolio
  • Careers
  • Investor Centre
  • News & Views

© Telix Pharmaceuticals Limited. 55 Flemington Road, North Melbourne, VIC 3051, Australia.

The Telix Pharmaceuticals and the Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved.
This website is intended for corporate communication purposes only and is not intended as promotion or advertising to any audience in any country worldwide.

Privacy Policy. Terms of Use. Cookies Policy. Privacy Settings